SEC Tracker
Get the app

Arcutis Biotherapeutics ARQT

Edwards Todd (officer) plans to sell 29,131 ARQT shares, about $732,926

Form
144/A
Filed
Importance
Routine
  1. Approximate sale date: Nov 6, 2025
  2. Broker: Merrill
  3. Shares acquired by: Restricted shares vest

All of Edwards Todd's insider filings, holdings and planned sales

Written from the Form 144/A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Arcutis Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Ligand Pharmaceuticals LGND public float $1.6B, Jun 30, 2025
  2. Ocular Therapeutix OCUL public float $1.6B, Jun 30, 2025
  3. Arrowhead Pharmaceuticals ARWR public float $1.4B, Mar 31, 2025, over 18 months old
  4. Sarepta Therapeutics SRPT public float $1.7B, Jun 30, 2025
  5. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.